Advertisement
U.S. pharmaceutical concern Johnson & Johnson on
Tuesday reported a fall in third quarter net income to $3 billion, or $1.15 a share, down from $3.2 billion in the same
period last year.
The 7.3 percent decline was attributed to increased research and
production costs.
Revenues rose to $17.1 billion, a rise of 6.5 percent over
the same quarter last year. The stronger dollar hurt the value of
foreign sales, which otherwise would have grown 10.8 percent over
the same quarter last year, the company said.
